T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Humana
HUM
|
+$2.57B |
| 2 |
GE Aerospace
GE
|
+$1.8B |
| 3 |
UnitedHealth
UNH
|
+$1.63B |
| 4 |
Marriott International
MAR
|
+$1.62B |
| 5 |
Apple
AAPL
|
+$1.3B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$2.87B |
| 2 |
JPMorgan Chase
JPM
|
+$1.64B |
| 3 |
Nike
NKE
|
+$1.59B |
| 4 |
Becton Dickinson
BDX
|
+$1.46B |
| 5 |
Alibaba
BABA
|
+$1.32B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.97% |
| 2 | Healthcare | 18.52% |
| 3 | Consumer Discretionary | 13.26% |
| 4 | Financials | 12.08% |
| 5 | Communication Services | 10.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
KYNB
676
Kyntra Bio
KYNB
$28.5M
| $71.3M | 0.01% |
82,079
-11,480
| -12% | -$11.4M |
|
677
Expro Ltd
XPRO
$2.1B
| $70.9M | 0.01% |
4,564,556
+1,175,231
| +35% | +$24.8M |
|
678
Williams Companies
WMB
$89.3B
| $70.9M | 0.01% |
5,011,412
+2,789,761
| +126% | +$54M |
|
|
HNGR
679
DELISTED
Hanger Inc.
HNGR
| $70.9M | 0.01% |
4,550,272
+48,194
| +1% | +$1.09M |
|
680
Targa Resources
TRGP
$57.2B
| $70.6M | 0.01% |
10,216,384
+5,381,053
| +111% | +$160M |
|
681
Phillips 66
PSX
$92.8B
| $70.5M | 0.01% |
1,314,100
+36,649
| +3% | +$2.98M |
|
|
WBA
682
DELISTED
Walgreens Boots Alliance
WBA
| $70.2M | 0.01% |
1,533,861
+117,784
| +8% | +$5.98M |
|
683
Americold
COLD
$4.32B
| $70.1M | 0.01% |
2,058,250
+191,527
| +10% | +$6.41M |
|
684
PagSeguro Digital
PAGS
$2.43B
| $69.7M | 0.01% |
3,606,426
+586,673
| +19% | +$17.8M |
|
685
Enanta Pharmaceuticals
ENTA
$391M
| $69.7M | 0.01% |
1,354,938
-41,397
| -3% | -$2.21M |
|
|
HMSY
686
DELISTED
HMS Holdings Corp.
HMSY
| $69.6M | 0.01% |
2,754,857
+196,520
| +8% | +$5.12M |
|
687
National Bank Holdings
NBHC
$1.94B
| $69.2M | 0.01% |
2,895,779
+106,152
| +4% | +$3.31M |
|
688
East-West Bancorp
EWBC
$18.6B
| $69.2M | 0.01% |
2,686,982
+335,019
| +14% | +$13.9M |
|
|
IBTX
689
DELISTED
Independent Bank Group, Inc.
IBTX
| $68.6M | 0.01% |
2,896,392
-6,597
| -0.2% | -$303K |
|
690
Celanese
CE
$4.86B
| $68M | 0.01% |
927,075
+542,613
| +141% | +$53.7M |
|
|
ETRN
691
DELISTED
Equitrans Midstream Corporation Common Stock
ETRN
| $67.4M | 0.01% |
13,407,119
-2,592,519
| -16% | -$22.7M |
|
692
Eaton
ETN
$176B
| $67.2M | 0.01% |
865,548
+64,366
| +8% | +$5.9M |
|
|
DISH
693
DELISTED
DISH Network Corp.
DISH
| $67.2M | 0.01% |
3,361,945
+535,710
| +19% | +$17.4M |
|
694
Clorox
CLX
$12.9B
| $67M | 0.01% |
386,931
-15,480
| -4% | -$2.56M |
|
695
Churchill Downs
CHDN
$6.2B
| $67M | 0.01% |
1,301,624
-228,894
| -15% | -$14.8M |
|
696
ICICI Bank
IBN
$106B
| $66.6M | 0.01% |
7,836,960
+654,171
| +9% | +$8.66M |
|
|
IMMU
697
DELISTED
Immunomedics Inc
IMMU
| $66.4M | 0.01% |
4,928,823
-899,168
| -15% | -$15.1M |
|
698
Glacier Bancorp
GBCI
$6.48B
| $66M | 0.01% |
1,941,990
+2,476
| +0.1% | +$98.7K |
|
|
SUM
699
DELISTED
Summit Materials, Inc. Class A Common Stock
SUM
| $66M | 0.01% |
4,475,620
+858,091
| +24% | +$16.7M |
|
700
Casella Waste Systems
CWST
$5.79B
| $66M | 0.01% |
1,689,966
-88,346
| -5% | -$4.28M |
|
Similar funds
T. Rowe Price Associates's Q1 2020 Portfolio in Review
As of Q1 2020, T. Rowe Price Associates held 2,612 positions worth $632B, down 18% from $771B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
T. Rowe Price Associates's Q1 2020 filing shows 87 new, 1,525 increased, 823 reduced and 103 closed positions. Its largest new stake was Philips: 33,363,001 shares worth $1.07B. The largest sale was Boeing, an estimated $2.87B.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 21% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q1 2020 buy was Philips: 33,363,001 shares worth $1.07B.
- T. Rowe Price Associates added most to Humana in Q1 2020, an estimated $2.57B increase.
- T. Rowe Price Associates's biggest Q1 2020 reduction was Boeing, cutting an estimated $2.87B.
- T. Rowe Price Associates fully exited Wellcare Health Plans, Inc. in Q1 2020, selling an estimated $846M.
- T. Rowe Price Associates's ten largest holdings make up 24% of its $632B portfolio in Q1 2020.
- T. Rowe Price Associates opened 87 new positions and closed 103 in Q1 2020.
- T. Rowe Price Associates's portfolio value fell 18% quarter-over-quarter to $632B.
Based on T. Rowe Price Associates's 13F filing for Q1 2020, filed 15 May 2020.